Fibroblasts and IPSC's
Patient fibroblast lines have been established at Coriell Institute for Medical Research and are available for purchase here https://www.coriell.org/Search?q=PACS1 .The foundation has signed a service agreement with Coriell to create iPSC Lines from the patient fibroblast lines (to be available summer 2019).
Jackson Labs is in the process of creating a knock-in mouse model under a rare disease NIH grant using CRISPR technique ( will be available late 2018)
CRISPR Knock-in cell-line
Systems Biosciences has contracted with the PACS1 Syndrome Research Foundation and has created CRISPR knock-in HELA cell lines that are available.